Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes

被引：0
作者：
Mark E. Hwang
Mark Mayeda
Maria Liz
Brenda Goode-Marshall
Lissette Gonzalez
Carl D. Elliston
Catherine S. Spina
Oscar A. Padilla
Sven Wenske
Israel Deutsch
机构：
[1] Columbia University Medical Center,Department of Radiation Oncology
[2] Columbia University Medical Center,Department of Urology
来源：
Radiation Oncology | / 14卷
关键词：
Prostate cancer; Stereotactic body radiotherapy; Rectal toxicity; SpaceOAR hydrogel; Dosimetry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: Toxicity, biochemical, and pathological outcomes
    Loblaw, Andrew
    Cheung, Patrick
    D'Alimonte, Laura
    Deabreu, Andrea
    Mamedov, Alexandre
    Zhang, Liying
    Tang, Colin
    Quon, Harvey
    Jain, Suneil
    Pang, Geordi
    Nam, Robert
    RADIOTHERAPY AND ONCOLOGY, 2013, 107 (02) : 153 - 158
  • [32] The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer—Quo Vadimus?
    Wee Loon Ong
    Andrew Loblaw
    World Journal of Urology, 2023, 41 : 3485 - 3491
  • [33] STEREOTACTIC BODY RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: INTERIM RESULTS OF A PROSPECTIVE PHASE II CLINICAL TRIAL
    King, Christopher R.
    Brooks, James D.
    Gill, Harcharan
    Pawlicki, Todd
    Cotrutz, Cristian
    Presti, Joseph C., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1043 - 1048
  • [34] Dosimetric and radiobiological comparison of Cyberknife and Tomotherapy in stereotactic body radiotherapy for localized prostate cancer
    Chen, Chun-You
    Lee, Liang-Ming
    Yu, Hsiao-Wei
    Lee, Steve P.
    Lee, Hsin-Lun
    Lin, Yung-Wei
    Wen, Yu-Ching
    Chen, Yi-Ju
    Chen, Chiu-Ping
    Tsai, Jo-Ting
    JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY, 2017, 25 (03) : 465 - 477
  • [35] Extreme hypofractionated stereotactic radiotherapy for localized prostate Cancer: Efficacy and late urinary toxicity according to transurethral resection of the prostate history
    Galienne, Maxime
    Risbourg, Severine
    Lacornerie, Thomas
    Taillez, Alexandre
    Lartigau, Eric
    Barthoulot, Mael
    Pasquier, David
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 46
  • [36] Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
    Kim, Hun Jung
    Phak, Jung Hoon
    Kim, Woo Chul
    PROSTATE INTERNATIONAL, 2015, 3 (04) : 118 - 122
  • [37] Stereotactic Body Radiotherapy for Primary Prostate Cancer
    Kothari, Gargi
    Loblaw, Andrew
    Tree, Alison C.
    van As, Nicholas J.
    Moghanaki, Drew
    Lo, Simon S.
    Ost, Piet
    Siva, Shankar
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [38] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
    Mekhail Anwar
    Vivian Weinberg
    Zachary Seymour
    I. Joe Hsu
    Mack Roach
    Alex R. Gottschalk
    Radiation Oncology, 11
  • [39] Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
    Debra E Freeman
    Christopher R King
    Radiation Oncology, 6
  • [40] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
    Anwar, Mekhail
    Weinberg, Vivian V.
    Seymour, Zachary
    Hsu, I. Joe
    Roach, Mack, III
    Gottschalk, Alex R.
    RADIATION ONCOLOGY, 2016, 11
12345